A detailed history of Voya Investment Management LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 173,044 shares of IOVA stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
173,044
Previous 172,885 0.09%
Holding current value
$1.48 Million
Previous $1.39 Million 17.17%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.28 - $11.9 $1,157 - $1,892
159 Added 0.09%
173,044 $1.62 Million
Q2 2024

Aug 14, 2024

SELL
$7.78 - $14.19 $210,277 - $383,527
-27,028 Reduced 13.52%
172,885 $1.39 Million
Q1 2024

May 15, 2024

BUY
$7.59 - $17.47 $295,167 - $679,390
38,889 Added 24.15%
199,913 $2.96 Million
Q4 2023

Feb 14, 2024

SELL
$3.3 - $8.89 $917 - $2,471
-278 Reduced 0.17%
161,024 $1.31 Million
Q3 2023

Nov 14, 2023

BUY
$4.44 - $8.79 $43,676 - $86,467
9,837 Added 6.49%
161,302 $733,000
Q2 2023

Aug 14, 2023

SELL
$5.36 - $9.06 $540,802 - $914,117
-100,896 Reduced 39.98%
151,465 $1.07 Million
Q1 2023

May 15, 2023

BUY
$5.53 - $8.22 $322,869 - $479,924
58,385 Added 30.1%
252,361 $1.54 Million
Q3 2022

Nov 14, 2022

BUY
$9.53 - $13.11 $1.31 Million - $1.8 Million
137,261 Added 242.02%
193,976 $1.86 Million
Q2 2022

Aug 15, 2022

BUY
$6.38 - $18.33 $127,127 - $365,243
19,926 Added 54.16%
56,715 $626,000
Q1 2022

May 16, 2022

SELL
$12.38 - $19.1 $4,258 - $6,570
-344 Reduced 0.93%
36,789 $613,000
Q4 2021

Feb 14, 2022

BUY
$16.55 - $27.63 $111,083 - $185,452
6,712 Added 22.06%
37,133 $709,000
Q3 2021

Nov 15, 2021

BUY
$20.35 - $26.63 $1,465 - $1,917
72 Added 0.24%
30,421 $750,000
Q2 2021

Aug 16, 2021

SELL
$16.33 - $33.07 $251,302 - $508,914
-15,389 Reduced 33.65%
30,349 $790,000
Q1 2021

May 17, 2021

SELL
$28.67 - $52.59 $81,996 - $150,407
-2,860 Reduced 5.89%
45,738 $1.45 Million
Q4 2020

Feb 16, 2021

SELL
$28.04 - $50.26 $8.03 Million - $14.4 Million
-286,239 Reduced 85.49%
48,598 $2.26 Million
Q3 2020

Nov 16, 2020

BUY
$27.75 - $36.3 $1.07 Million - $1.4 Million
38,485 Added 12.99%
334,837 $11 Million
Q2 2020

Aug 14, 2020

SELL
$27.21 - $41.0 $5.83 Million - $8.79 Million
-214,390 Reduced 41.98%
296,352 $8.14 Million
Q1 2020

May 15, 2020

SELL
$19.54 - $38.85 $2.86 Million - $5.69 Million
-146,579 Reduced 22.3%
510,742 $15.3 Million
Q4 2019

Feb 14, 2020

SELL
$17.95 - $29.41 $6.4 Million - $10.5 Million
-356,469 Reduced 35.16%
657,321 $18.2 Million
Q3 2019

Nov 14, 2019

BUY
$17.99 - $26.0 $8.95 Million - $12.9 Million
497,487 Added 96.36%
1,013,790 $18.5 Million
Q2 2019

Aug 14, 2019

BUY
$9.78 - $24.52 $4.63 Million - $11.6 Million
473,008 Added 1092.52%
516,303 $12.7 Million
Q4 2018

Feb 14, 2019

BUY
$7.51 - $11.93 $77,878 - $123,714
10,370 Added 31.5%
43,295 $383,000
Q2 2018

Aug 14, 2018

BUY
$12.45 - $16.95 $20,355 - $27,713
1,635 Added 5.23%
32,925 $421,000
Q1 2018

May 15, 2018

BUY
$8.1 - $19.5 $39,552 - $95,218
4,883 Added 18.49%
31,290 $529,000
Q4 2017

Feb 14, 2018

SELL
$6.65 - $9.25 $12,136 - $16,881
-1,825 Reduced 6.46%
26,407 $211,000
Q3 2017

Nov 14, 2017

BUY
$4.45 - $8.55 $125,632 - $241,383
28,232
28,232 $219,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.35B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.